In support of this hypothesis, we found that the percentage of Foxp3+/Tim-3+ CD4 T cells (Foxp3+/Tim-3+%) in TILs correlated positively with the TNM stage of the HCC patients. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.